Location History:
- Donabate, IE (2005)
- Dublin, IE (2009)
Company Filing History:
Years Active: 2005-2009
Title: The Innovative Mind of Lisa Higgins: Pioneering Intestinal Targeting Ligands
Introduction: Lisa Higgins, a distinguished inventor based in Dublin, Ireland, has made remarkable contributions to the field of pharmaceuticals with her innovative inventions. With two patents to her name, Higgins focuses on developing methods and compounds that target specific intestinal tissues, demonstrating her commitment to advancing medical science.
Latest Patents: Lisa Higgins’ latest patents revolve around Peyer's patch and M-cell targeting ligands. These patents include purified synthetic polypeptide ligands designed to target pharmaceutical agents to intestinal epithelial tissue, specifically Peyer's patch and M-cell tissues. The first patent discusses the creation of these ligands, emphasizing their composition as a 12-mer L-peptide, D-peptides, retro-inverted peptides, and their respective fragments and homologues. Additionally, the patents outline methods for using these ligands effectively, highlighting their potential in delivering pharmaceutical agents efficiently to the intended sites.
Career Highlights: Higgins has built a significant career in research and innovation, contributing to key advancements in pharmaceutical technologies. Her work at Merrion Research III Limited and Merrion Research I Limited has further established her as a leader in her field, where her passion for innovation continues to shape the landscape of drug delivery systems.
Collaborations: Throughout her career, Lisa Higgins has collaborated with notable colleagues such as Daniel Joseph O'Mahony and Imelda Lambkin. These partnerships have not only enhanced her research capabilities but have also fostered an environment of innovation and creativity in their collective endeavors.
Conclusion: Lisa Higgins stands out as a prominent inventor in the field of pharmaceutical innovation. Her patented work on targeting ligands for Peyer's patches and M-cells showcases her dedication to improving drug delivery methods, ultimately contributing to better healthcare outcomes. With a promising career ahead, Higgins continues to inspire future generations of inventors.